ClearPoint Neuro (NASDAQ:CLPT – Get Free Report) and Milestone Scientific (NYSE:MLSS – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, profitability, institutional ownership and analyst recommendations.
Insider & Institutional Ownership
30.1% of ClearPoint Neuro shares are owned by institutional investors. Comparatively, 5.8% of Milestone Scientific shares are owned by institutional investors. 6.9% of ClearPoint Neuro shares are owned by insiders. Comparatively, 9.2% of Milestone Scientific shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Profitability
This table compares ClearPoint Neuro and Milestone Scientific’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| ClearPoint Neuro | -81.76% | -188.09% | -40.88% |
| Milestone Scientific | -52.01% | -60.26% | -40.23% |
Analyst Recommendations
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| ClearPoint Neuro | 1 | 0 | 2 | 0 | 2.33 |
| Milestone Scientific | 0 | 0 | 1 | 0 | 3.00 |
ClearPoint Neuro presently has a consensus price target of $25.67, suggesting a potential upside of 73.07%. Milestone Scientific has a consensus price target of $1.00, suggesting a potential upside of 143.49%. Given Milestone Scientific’s stronger consensus rating and higher probable upside, analysts plainly believe Milestone Scientific is more favorable than ClearPoint Neuro.
Volatility & Risk
ClearPoint Neuro has a beta of 1.26, indicating that its share price is 26% more volatile than the S&P 500. Comparatively, Milestone Scientific has a beta of 1.08, indicating that its share price is 8% more volatile than the S&P 500.
Earnings and Valuation
This table compares ClearPoint Neuro and Milestone Scientific”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| ClearPoint Neuro | $36.97 million | 12.23 | -$25.54 million | ($1.18) | -12.57 |
| Milestone Scientific | $9.42 million | 3.95 | -$6.93 million | ($0.04) | -10.27 |
Milestone Scientific has lower revenue, but higher earnings than ClearPoint Neuro. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Milestone Scientific, indicating that it is currently the more affordable of the two stocks.
Summary
Milestone Scientific beats ClearPoint Neuro on 9 of the 14 factors compared between the two stocks.
About ClearPoint Neuro
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.
About Milestone Scientific
Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.
Receive News & Ratings for ClearPoint Neuro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ClearPoint Neuro and related companies with MarketBeat.com's FREE daily email newsletter.
